← Back to patent-cliff list
米非司酮/米索前列醇
Tier C — Watch / tradeMifepristone/Misoprostol
印度太阳药业有限公司
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PTGER2、PR
Brand：Mifegymiso、Medabon、MS-2 Step、MEFEEGO
Indications (approved)：终止妊娠
Regional status
US
-
EU
批准上市
2012-01-01
China
-
Japan
批准上市
2023-04-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Mifepristone/Misoprostol?
Approved indications include: 终止妊娠.
When does the Mifepristone/Misoprostol patent expire?
No public expiry year is available for Mifepristone/Misoprostol yet; this page updates once verified.
How do I get a quote for Mifepristone/Misoprostol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24